E. F. Silveira

A hybrid of two major Blomia tropicalis allergens as an allergy vaccine candidate

P. Lackner, P. Briza, Á. Cruz, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

N‐terminal peptide deletion influences immunological and structural features of Blo t 5

P. Briza, M. Chapman, M. Wallner, 2020, Allergy.

Removal of N-Terminal Peptide Impacts Structural Aspects of an IgE-Reactive Recombinant Der p 5

N. Alcântara-Neves, J. Fernandes, A. M. S. Fernandes, 2023, Allergies.

Recombinant T‐cell epitope conjugation: A new approach for Dermatophagoides hypoallergen design

F. Ferreira, N. Alcântara-Neves, A. Jacquet, 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Purification and characterisation of the dimeric group 12 allergen from Blomia tropicalis heterologously expressed by Escherichia coli Top10F´

N. Alcântara-Neves, C. Asam, A. M. S. Fernandes, 2021, Molecular Biology Reports.

The hybrid protein BTH2 suppresses allergic airway inflammation in a murine model of HDM‐specific immunotherapy

L. Caraballo, F. Ferreira, N. Alcântara-Neves, 2023, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Immunogenicity and protection induced by recombinant Toxocara canis proteins in a murine model of toxocariasis.

P. Cooper, N. Alcântara-Neves, S. M. Barrouin-Melo, 2020, Vaccine.